Inventor · disambiguated record
Colin J. Meyer
Also filed as: MEYER COLIN · MEYER COLIN J
9 granted patents·7 pending applications·230 citations·filing 2008–2024
89Inventor score
Files withREATA PHARMACEUTICALS INC7REATA PHARMACEUTICALS HOLDINGS LLC4SPORN MICHAEL B2MEYER COLIN1MEYER COLIN J1
Top patents by PatentIndex Score
16 records- 0198US8129429B2Synthetic triterpenoids and methods of use in the treatment of diseaseSPORN MICHAEL B·Filed 2009·Granted Mar 6, 2012·119 cites·40 claims
- 0296US8455544B2Synthetic triterpenoids and methods of use in the treatment of diseaseSPORN MICHAEL B·Filed 2012·Granted Jun 4, 2013·57 cites·30 claims
- 0394US8747901B2Delayed release, oral dosage compositions that contain amorphous CDDO-MeZHANG JIANG·Filed 2010·Granted Jun 10, 2014·19 cites·11 claims
- 0493US9757359B2Synthetic triterpenoids and methods of use in the treatment of diseaseREATA PHARMACEUTICALS INC·Filed 2013·Granted Sep 12, 2017·16 cites·25 claims
- 0587US9155721B2Delayed release, oral dosage compositions that contain amorphous CDDO-MeREATA PHARMACEUTICALS INC·Filed 2014·Granted Oct 13, 2015·4 cites·16 claims
- 0684US10105372B2Methods of treating obesity using antioxidant inflammation modulatorsMEYER COLIN J·Filed 2011·Granted Oct 23, 2018·14 cites·23 claims
- 0781US11911395B2Methods of treating obesity using antioxidant inflammation modulatorsREATA PHARMACEUTICALS INC·Filed 2018·Granted Feb 27, 2024·1 cites·26 claims
- 0876US2024115542A1Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereofREATA PHARMACEUTICALS HOLDINGS LLC·Filed 2023·Application pending·0 cites
- 0976US2024335457A1Methods of treating obesity using antioxidant inflammation modulatorsREATA PHARMACEUTICALS HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 1067US11446313B2Methods of treating Alport syndrome using bardoxolone methyl or analogs thereofREATA PHARMACEUTICALS HOLDINGS LLC·Filed 2021·Granted Sep 20, 2022·0 cites·30 claims
- 1167US2015080465A1Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereofREATA PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1265US2019091194A1Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereofREATA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1364US10953020B2Methods of treating Alport syndrome using bardoxolone methyl or analogs thereofREATA PHARMACEUTICALS INC·Filed 2017·Granted Mar 23, 2021·0 cites·24 claims
- 1458US2018161311A1Synthetic triterpenoids and methods of use in the treatment of diseaseREATA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1558US2009048205A1Combination therapy with synthetic triterpenoids and gemcitabineMEYER COLIN·Filed 2008·Application pending·0 cites
- 1653US2023255982A1Methods of treating covid-19 using bardoxolone methyl or analogs thereofREATA PHARMACEUTICALS HOLDINGS LLC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Colin J. Meyer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →